Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 10Lymphoid 1Head & Neck 1

Conditions

Head and Neck Neoplasms 8Squamous Cell Carcinoma of Head and Neck 4Lymphoma 2Lung Neoplasms 2Uterine Cervical Neoplasms 1Thyroid Nodule 1Sinusitis 1Rectal Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms 1Mouth Neoplasms 1Melanoma 1Lymphatic Metastasis 1Hearing Loss 1Glioma 1Colonic Neoplasms 1Cholesteatoma 1Carcinoma, Squamous Cell 1Brain Neoplasms 1Anus Neoplasms 1

Interventions

trametinib 3dabrafenib 3binimetinib 2Nivolumab 2Magnetic Resonance Spectroscopy 2Docetaxel 2Cisplatin 2ulixertinib 1trastuzumab biosimilar HLX02 1tipifarnib 1sapanisertib 1romidepsin 1relatlimab 1pertuzumab 1palbociclib 1osimertinib 1omipalisib 1larotrectinib 1ipatasertib 1erdafitinib 1entrectinib 1entinostat 1durvalumab 1defactinib 1copanlisib 1cobimetinib 1capivasertib 1cabiralizumab 1adavosertib 1X-Rays 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioma × Magnetic Resonance Imaging × Head & Neck × Clear all
NCT03212157 2021-09-29

GlucoCEST MRI in Oncology

University College, London

Phase NA Completed
15 enrolled
CNSHead & NeckLymphoid

Squamous Cell Carcinoma of Head and Neck, Glioma, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡